Skip to main content
letter
. 2004 Feb;88(2):303–305. doi: 10.1136/bjo.2003.023945

Table 1.

Clinical profile of the control group, non-DR group, and PDR group

Control group Non-DR group PDR group p Value
Number of patients 50 45 44
Age (years)† 27.4 (2.7) 27.8 (2.8) 29.2 (4.1) NS
Male/female 25/25 20/25 20/24
Age at the diagnosis of diabetes (years) 16.5 (4.3) 16.7 (3.7) NS*
Age at the diagnosis of diabetic retinopathy (years) 21.6 (4.5)
Age at the time of vitreous surgery (years) 28.8 (4.4)
HbA1C (%) 7.7 (1.6) 7.9 (1.9) NS*
Hypertension (%) 0 (0.0%) 3 (6.7%) 4 (8.3%) NS**
Renal disease (%) 0 (0.0%) 6 (13.3%) 15 (34.1%) .0021**
Neurophysiological neuropathy (%) 0 (0.0%) 9 (20.0%) 18 (40.9%) .032**
Positive family history (%) 0 (0.0%) 15 (33.3%) 19 (43.1%) NS**

Number of patients or mean (SD).

NS  =  not significant.

The age was compared between each group.

*Comparisons between the non-DR group and the PDR group by unpaired t test.

**Comparisons between the non-DR group and the PDR group χ2 test of independence or Fisher’s exact probability test.

†Age at the time of this study.

¶Average value over 10 years.